Trial Profile
Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary)
- Indications Multiple myeloma
- Focus Expanded access; Therapeutic Use
- 23 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
- 23 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov record.